Boston Scientific (BSX) Other Operating Expenses (2009 - 2026)

Boston Scientific (BSX) has 17 years of Other Operating Expenses data on file, last reported at $213.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 10.5% year-over-year to $213.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (down 14.8% YoY), and the FY2025 full-year result was $1.1 billion, changed N/A from the prior year.
• Other Operating Expenses retreated to $213.0 million in Q1 2026, from $342.0 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $500.0 million in Q2 2024 to a low of -$22.0 million in Q4 2022.
• A 5-year average of $234.8 million and a median of $239.0 million in 2024 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses sank 173.33% in 2022 and soared 431.82% in 2023, its largest moves.
• Tracing BSX's Other Operating Expenses over 5 years: stood at -$22.0 million in 2022, then soared by 431.82% to $73.0 million in 2023, then surged by 372.6% to $345.0 million in 2024, then decreased by 0.87% to $342.0 million in 2025, then tumbled by 37.72% to $213.0 million in 2026.
• Business Quant data shows BSX's Other Operating Expenses at $213.0 million in Q1 2026, $342.0 million in Q4 2025, and $247.0 million in Q3 2025.